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Endothelium 
The blood vessels are mainly constituted by three layers. The 
outermost layer is called adventitia composed by connective 
elements (eg. fibroblasts and collagen fibers), nerves ending and 
perivascular adipose tissue. The medial layer is constituted by 
smooth muscle which mediates the contraction or dilation of the 
blood vessels initiated by agonists or mechanical stimulus such 
as shear stress. The last one and most complex is denominated 
intimal or endothelium (Ignarro, 1989).
It is well known that vascular endothelium plays a pivotal 
role in the control of the vascular function and in the vessel mor-
phology; however, this concept emerged over the years. Briefly, 
in 1800s, von Reckingausen determined that blood vessels were 
lined by cells. In 1865, the German anatomist Wilhelm His 
combined Greek words and proposed the word “endothelium” 
as complementary term to “epithelium”. Currently, there is a 
consensus to use this word to describe a cell layer that surrounds 
the entire vascular tree, from the heart to the smallest capillaries 
and even lymphatic vessels (Favero, Paganelli, Buffoli, Rodella, 
& Rezzani, 2014; Thorgeirsson & Jr, 1978; Zhao, Vanhoutte, 
& Leung, 2015). 
It well established that endothelium is a monolayer, com-
posed by endothelial cells (ECs), representing an interface 
between the blood and the vascular wall. Earliest studies be-
lieved that ECs have no other functions than the maintenance 
of permeability to water and electrolytes. In 1950, studies 
conducted using electron microscopy, provided details and 
guided in the construction of the current concept of endothelium 
as a dynamic and active organ with secretory, metabolic and 
immunologic functions. Another important discovery emerged 
in 1980, when Furchgott and Zawadzki (1980) demonstrated 
the obligatory role of ECs presence in the relaxation of blood 
vessels after acetylcholine stimulation in isolated preparation 
of rabbit aorta. They demonstrated by the first time that the 
denuded endothelium (ECs were removed), caused lower re-
laxing response or even this response could be replaced by a 
vasoconstriction. They proposed that an endothelium-derived 
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relaxing factor might be release from ECs in vascular tissue, 
later this factor was identified as nitric oxide (Higashi, 2015; 
Vanhoutte, Shimokawa, Feletou, & Tang, 2015).
Surprisingly, ECs surface in an adult human, is composed of 
approximately 1 to 6 x 1013 cells and its total length is enough 
to 2.5 times around the globe. A number of membrane-bound 
receptors for proteins exist in the ECs, such as growth factors, 
coagulant, and anticoagulant proteins, lipid transporting parti-
cles (eg, low-density lipoprotein), metabolites (eg, serotonin), 
hormones (eg, endothelin-1). In addition, the angiotensin-con-
verting enzyme is present in the ECs as well as mechanosensors 
which are for responsible for ECs in detecting mechanical 
forces and translating in chemical signal governing cell-cell and 
cell-matrix interactions in vascular system (Cines et al.,1998; 
Flammer et al., 2012; Rajendran et al., 2013).
Therefore, this intimal layer is not only a structural barrier 
separating the vessels wall from the circulating blood, but also 
releases a number of mediators that act in an autocrine and 
paracrine way to maintain the homeostasis of the cardiovas-
cular system. The exchange of fluid and molecules between 
blood and tissues, generation of new vascular beds (angio-
genesis) and modulation of the immunologic, fibrinolytic and 
coagulation responses are some of the multiple roles of ECs 
(Avogaro, Kreutzenberg, & Fadini, 2008; Cines et al., 1998; 
Donato, Morgan, Walker, & Lesniewski, 2015). In addition, 
ECs play a major role in controlling vascular tone and studies 
of vasoreactivity is a well known approach used by detecting 
alterations of ECs and vascular system in some pathological 
states as well as the modulation of the vascular resistance in 
response to changes in blood flow in physiological state such 
as physical exercise (Cines et al., 1998; Avogaro et al., 2008; 
Delbin & Trask, 2014; Donato et al., 2015).
Endothelial cells produce and release vasoconstrictors and 
vasodilators substances and a balance between them is required 
to maintain vascular homeostasis. The vasoconstriction is me-
diated mainly by endothelin-1 (ET-1), angiotensin II (ANG II), 
thromboxane A2 (TX
A2
), prostaglandin (PG
H2
) and reactive ox-
ygen species (ROS). The vasodilation effect of ECs is mediated 
by factors such as nitric oxide (NO), endothelium-derived hy-
perpolarizing factor (EDHF) and prostacyclin (PG
I2
). Although 
all these mediators have a significant role in the vascular system, 
NO is considered the most important endothelial-derived factor 
(Park & Park, 2015; Vanhoutte et al., 2015). 
The NO is a free radical, highly diffusible,  and it was the 
first gaseous molecule to be accepted as a signaling mediator 
in the organism. NO is produced by three NO synthases (NOS) 
isoforms using the amino acid L-arginine as a substrate. The 
neuronal NOS (nNOS or NOS-1) is more expressed in neurons, 
skeletal muscle, and the NO produced plays a role in the com-
munication between cells. The inducible NOS (iNOS or NOS-2) 
is expressed in macrophages/monocytes and its induction occurs 
especially during pathological conditions such as infections and 
chronic inflammatory diseases. The endothelial NOS (eNOS 
or NOS-3) is present in the endothelial cells, thus is the major 
isoform responsible to regulate the vascular system. All these 
enzymes have similar mechanisms to produce NO, oxidizing 
the terminal guanidine nitrogen of L-arginine and several 
cofactors are required including tetrahydrobiopterin - BH4, 
nicotinamide-adenine-dinucleotide phosphate - NADPH, flavin 
adenine dinucleotide - FAD, and flavin mononucleotide - FMN) 
to exert their function (Fleming, 2010; Lundberg, Gladwin, & 
Weitzberg, 2015; Zhao et al., 2015).
The eNOS activity is stimulated by various chemical ago-
nists such as acetylcholine, bradykinin and histamine. These 
substances activate their specific receptors present in the ECs, 
which in turn, increase the intracellular calcium concentration 
stimulating the catalytic unit of the enzyme. In a calcium-inde-
pendent pathway, increased NO production can also be induced 
by mechanical stimulus such as shear stress, which induces 
the phosphorylation of eNOS through the protein kinase A. 
Particularly, physical exercise is a powerful stimulus to pro-
mote vascular shear stress activating mechanosensors. These 
mechanosensors are coupled to complex biochemical signal 
pathways, such as Ras/MEK/ERK, c-Src, G proteins, ion chan-
nel, VE-cadherin, and PI3K/Akt, which in turn regulate NO/
cGMP pathway (Balligand, Feron, & Dessy, 2009). 
Considered the most potent endogenous vasodilator, NO 
diffuses from ECs into the underlying smooth muscle cells and 
activates soluble guanylate cyclase (sGC), which generates the 
cyclic guanosine monophosphate (cGMP). In the vasculature, 
this second messenger activates the protein kinase G, promoting 
the reuptake of cytosolic calcium to the sarcoplasmic reticulum, 
the extrusion of calcium out of the cell, and the opening of calci-
um-dependent potassium channels. As a result of these cellular 
events, there is a decrease in intracellular calcium concentration, 
promoting the vasodilation.  In addition, NO also acts inhibiting 
platelet aggregation, leukocyte adhesion, attenuation of vascular 
smooth muscle cell proliferation and migration, mitochondrial 
function, oxidative stress and inflammation. Thus, NO is a 
fundamental protective element to maintain the integrity of 
endothelium and the homeostasis of the cardiovascular sys-
tem (Lundberg et al., 2015; Strisciuglio et al., 2014; Versari, 
Daghini, Virdis, Ghiadoni, & Taddei, 2009; Zhao et al., 2015).
Given the fundamental role of ECs in vascular biology, 
different experimental approaches were established to examine 
endothelium function under physiological and pathological 
states. In experimental model using different animal species, the 
endothelium function is evaluated using isolated tissues such as 
aorta, coronary artery, mesenteric artery and femoral artery.  In 
human trials, the most common approach to assess endothelial 
function is the flow-mediated dilatation.
Assessment of endothelial function 
Endothelial dysfunction is a condition characterized by 
loss of the physiological properties of ECs, with impairment 
of relaxing property and a greater vasoconstrictor response.
This unbalance is believed to be as consequence of reduced 
NO production and/or its bioavailability  to the surrounding 
tissues (Avogaro et al., 2008; Endemann & Schiffrin, 2004; 
Strisciuglio et al., 2014). Endothelial dysfunction also causes 
thromboembolic disease and pro-inflammatory state by NO 
deficiency. Endothelial dysfunction is implicated in the genesis 
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of many chronic diseases including cardiovascular diseases 
(CVD) including coronary artery disease (CAD), peripheral 
artery disease (PAD), atherosclerosis, hypertension (HAS), 
diabetes and chronic kidney disease. Moreover, endothelial 
dysfunction can be observed in the early stage of CVD, espe-
cially atherosclerosis and, has independent prognostic value to 
acute cardiovascular events for subjects with or without CAD 
(Halcox et al., 2002; Yang et al., 2010). Thus, early detection 
of endothelial dysfunction is essential in preventing and even 
identification of a reversible step in the development of these 
cardio-metabolic disorders (Park & Park, 2015; Strisciuglio et 
al., 2014; Widlansky, Gokce, Keaney  Jr., & Vita, 2003).
Therefore, the development of clinical tests for evaluating 
the normal or activated properties of endothelium is extremely 
useful in both clinical and basic research fields (Deanfield, 
Halcox, & Rabelink, 2007; Higashi, 2015). As a model of 
excellence, the tests should be safe, noninvasive, cheap, repro-
ducible, and standardized between research groups. However, 
no single test currently applied can fill all the proposed require-
ments (Deanfield et al., 2007). Additionally, all of them have 
advantages and disadvantages. The principle of the analysis is 
normal arteries dilate in response to pharmacological stimulus 
(eg, acetylcholine, bradykinin, or serotonin) or to mechanical 
stimulus (reactive hyperemia). The dilation response is mainly 
due the release of NO and other endothelium-derived vaso-
dilator substance, characterizing the endothelium-dependent 
dilation. On the other hand, exogenous NO donators, such as 
glycerol-trinitrate, can be administrated to evaluate the endo-
thelium-independent vasodilation, promoting modifications 
and alterations directly into the smooth muscles cells bypassing 
endothelium layer (Flammer et al., 2012).
Many endothelium tests have been used to examine endo-
thelium function such as angiography, venous occlusion ple-
thismography, flow-mediated dilatation and peripheral arterial 
tonometry. However, invasive techniques, especially angiogra-
phy, are not adequate for investigation of early development of 
vascular injury in symptom-free subjects and cannot be used a 
as screening way of general population or for studies with pro-
gression and reversibility (Celermajer et al., 1992; Tousoulis, 
2005)preceding formation of plaques. We have devised a 
non-invasive method for testing endothelial function, to find out 
whether abnormalities are present in symptom-free children and 
young adults at high risk of atherosclerosis. With high-resolution 
ultrasound, we measured the diameter of the superficial femoral 
and brachial arteries at rest, during reactive hyperaemia (with 
increased flow causing endothelium-dependent dilatation. On 
the other hand, flow-mediated dilatation is considered the less 
invasive and safer for clinical and basic research.
Flow-mediated dilation (FMD)
David Celejamer and colleagues (1992) developed a non-in-
vasive method, known as flow-mediated dilation (FMD), to 
evaluate early changes in vascular function in systemic arteries, 
using a high-resolution ultrasound. It is expressed as a percent-
age change of the arterial diameter from the baseline diameter 
(Corretti et al., 2002; Harris, Nishiyama, Wray, & Richardson, 
2010). FMD has been extensively used in clinical research and it 
is currently considered a standard for a noninvasive assessment 
of conduit artery endothelial function (Deanfield et al., 2007; 
Higashi, 2015). In addition, it was demonstrated a positive cor-
relation between coronary response to acetylcholine and brachial 
vasodilator response to reactive hyperemia consolidating the 
use of this method (Anderson et al., 1995). 
During the test, vasodilation is usually evaluated in the 
brachial artery and occurs in response to the significant increase 
in blood flow, induced by a period of circulatory occlusion. 
Reactive hyperemia is induced by rapid release of a pneumatic 
pressure cuff placed around the forearm inflated to suprasystolic 
pressure for 5 min. This procedure is able to increase shear 
stress exerted along the vessel, in a parallel and laminar way, 
activating mechanoreceptors in ECs, promoting the release of 
NO (Corretti et al., 2002; Harris et al., 2010; Thijssen et al., 
2011)hypertension and heart failure. In the 1990s, high-frequen-
cy ultrasonographic imaging of the brachial artery to assess 
endothelium-dependent flow-mediated vasodilation (FMD. 
Nevertheless, some authors have been stated that the response 
can not to be only attributed to NO participation (Green, Jones, 
Thijssen, Cable, & Atkinson, 2011). Despite being a consolidat-
ed method, it requires  a great technical skill from investigator, 
there are no possibilities to correct for measurement-induced 
change in the systemic hemodynamics because is measured only 
one arm and; standardization is also a crucial point (Moerland 
et al., 2012; Widlansky et al., 2003). In addition, it has been 
pointed out that FMD percentage index can itself generates 
problems related to baseline diameter-dependency, which can 
led to biased comparisons of different conditions or populations. 
It should be emphasized that the researchers had to apply the 
allometric principles to scale FMD index and improve the in-
terpretation of the protocol and results (Atkinson & Batterham, 
2013, 2015; Atkinson, 2014)albeit with small samples, that the 
scaling properties of FMD% can lead to biased inferences on 
endothelial dysfunction. Therefore, we aimed to investigate 
the underlying rationale and potential bias of FMD% using a 
selection of new examples from the large (n = 3499. Please see 
the Figure 1 for more details.
Peripheral arterial tonometry 
Testing endothelial function with peripheral arterial tonome-
try (PAT) has gained attention as an alternative method to FMD. 
PAT device (EndoPAT-2000; Itamar Medical, Caesarea, Israel) 
was originally developed to evaluate vascular changes asso-
ciated with arousal during sleep and then, applied to vascular 
reactivity tests by Kuvin and colleagues in 2003 (Bruno, Gori, 
& Ghiadoni, 2014; Hamburg & Benjamin, 2009; Hedetoft & 
Olsen, 2014). It consists of finger-mounted probe plethismog-
raphy used to measure pulsatile arterial volume changes during 
each pulsation at rest and during reactive hyperemia, due the 
increase of shear stress. The finger probes contain electronically 
controllable inflatable chambers, which exert a pressure (70 
mmHg) across the finger, preventing venous pooling and blood 
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stasis. Moreover, the finger is well perfused and the absence 
of significant muscle mass facilitates the measurements. PAT 
examination include three moments including baseline, occlu-
sion (5 minutes) and reactive hyperemia (5 minutes), similar 
to FMD test. A cuff is placed around the tested arm by reactive 
hyperemia as well as a finger probe. A second finger probe is 
placed on the contralateral finger as a control measurement. 
During the exam, the PAT signal is transmitted to a specific 
software where will be processed and stored for further analysis 
(Hedetoft & Olsen, 2014).
The physiological response to PAT is not completely un-
derstood, but it seems to be partly related to NO participation 
(Nohria et al., 2006). It correlates with FMD of patients with 
cardiovascular risk factors (Kuvin et al., 2003) and can predict 
cardiovascular events (Rubinshtein et al., 2010). However, 
conflicting evidence contesting correlation existence between 
PAT and FMD have been reported (Allan, Delaney, Miller, 
& Spark, 2013; Hamburg et al., 2011; Lind, 2013). For some 
authors, PAT reflects vasodilator response in microvasculature 
only, while FMD measures in conduit arteries or macrovascu-
lature, which could justify the absence of correlation between 
them, depending on the vessel size and location (Dhindsa et 
al., 2008; Frolow, Drozdz, Kowalewska, Nizankowski, & 
Chlopicki, 2015; Hamburg & Benjamin, 2009; Hamburg et al., 
2011). Thus, PAT examination provides a distinct measurement 
of endothelial function compared with FMD, but it remains a 
convenient and advantageous technique to evaluate vascular 
function (Flammer et al., 2012; Hamburg et al., 2011). The 
main advantages include easy access, operator-independent, 
automated calculation and controlled by contralateral arm. On 
the other hand, it is a very expensive approach because finger 
probes is not reusable, endothelium-independent function is not 
a reliable measure and is highly influenced by sympathetic tone 
(Hamburg & Benjamin, 2009).
Diabetes, endothelial dysfunction and exercise
Diabetes Mellitus (DM) is a group of metabolic diseases 
characterized by hyperglycemia due to defects in insulin se-
cretion, action or both. The chronic state of hyperglycemia 
is associated with damage of several organs, especially eyes, 
kidneys, heart and blood vessel (American Diabetes Association, 
2005). Vascular disease is the main cause of death and morbidity 
in both type 1 (T1DM) and type 2 (T2DM) diabetes mellitus, 
affecting small and large vessels (Calles-Escandon & Cipolla, 
2001; Kirpichnikov & Sowers, 2001). Microvascular complica-
tions affect especially nervous system (neuropathy), the retina 
(retinopathy) and kidneys (nephropathy), while macrovascular 
disorders affect large vessels that can lead to early myocardial 
infarctions, ischaemic events, stroke and premature deaths 
(Harcourt, Penfold, & Forbes, 2013). Interestingly, glycemic 
control delays the development of microvascular injuries, but 
unfortunately, this effect is less pronounced than on the reduction 
of macrovascular diseases (Rask-Madsen & King, 2013; Sena, 
Pereira, & Seiça, 2013). 
Recent studies show that DM doubles the risk of total cardio-
vascular disease in men, and triples it in women. After adjust-
ment of age, relative risk was higher for women than for men 
in all complications analyzed which includes congestive heart 
failure, intermittent claudication, stroke, coronary heart disease, 
and cardiovascular disease deaths (Qazi & Malik, 2013).
A large number of evidences suggest that endothelial dys-
function is the main etiological factor for micro and macro 
vascular complications in DM (Avogaro et al., 2008; Calles-
Escandon & Cipolla, 2001). An impairment of endothelium 
response in experimental model of T1DM (Claudino et al., 
2011; Shi & Vanhoutte, 2008), T2DM (Bunker et al., 2010; 
Lee, Park, Dellsperger, & Zhang, 2011), as well as, in clinical 
studies including both type (Johnstone et al., 1993; Lekakis et 
Figure 1. Flow-mediated dilation (FMD) is non-invasive technique using high-esolution ultrasound on the brachial artery composed by three phases. NO:
nitric oxide A. After rest time, baseline arterial diameter should be performed. B. The stimuIus for the FMD test depends on vascular occlusion period.
At this moment, the cuff is inflated above the systolic values for 5 minutes. C. The measurement of arterial diameter after the cuff release (peak of
response between 45 to 60 seconds), characterizing the hyperemic period.
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Figure 1. Flow-mediated dilation (FMD) is non-invasive technique using high-resikution ultrasound on the brachial artery composed by three 
phases. NO: nitric oxide A. After rest time, baseline arterial diameter should be performed. B. The stimulus for the FMD test depends on vascular 
occlusion period. At this moment, the cuff is inflated above the systolic values for 5 minutes. C. The measurement of arterial diamenter after the 
cuff release (peak of response between 45 to 60 seconds). characterizing the hyperemic period.
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al., 1997) of diabetic patients (Henry et al., 2004; Williams, 
Cusco, Roddy & Johnstone, 1996) have been found. However, 
in T1DM, metabolic changes related to hyperglycemia seem to 
be the major trigger for the endothelial dysfunction. Unlike, the 
relationship between T2DM and impaired endothelial function is 
more complex because this process starts before the diagnostic 
of diabetes, with factors such as obesity, dyslipidemia, insulin 
resistance (Eringa et al., 2013; Sena et al., 2013). 
Oxidative stress is a hallmark of diabetic state that contribute 
to vascular damage. This condition describes an exacerbated 
ROS production, especially of superoxide, which overcomes the 
antioxidant defense. All the layer of the blood vessels are able to 
produce them, and the major source of ROS in vascular tissue 
seems to be from NADPH oxidase. Another sources of ROS are 
represented by mitochondria, xanthine oxidase, lipoxygenase 
and others (Delbin & Trask, 2014; Rask-Madsen & King, 2013; 
Sena et al., 2013). Increased ROS generation are related with 
abnormalities on structural and functional properties of eNOS 
by downregulation of phosphoinositide 3-kinase and PI3K/Akt 
signaling pathway in vascular endothelium; thus, decreasing NO 
production to the vascular smooth muscle. The adverse effects of 
this imbalance between oxidant and antioxidant molecules are 
related with diminished NO bioavailability, formation of per-
oxynitrite (ONOO-) and uncoupling of eNOS. (Hwang & Kim, 
2014; Park & Park, 2015; Toda, Imamura, & Okamura, 2010). 
Hyperglycemia also leads to the modification of extracellular 
and intracellular proteins resulting in advanced glycation end 
products (AGEs). In endothelial cells, the interaction between 
AGEs and their receptor (RAGE) can promote the activation of 
pro-inflammatory and activation of ROS production signaling 
pathways (Delbin & Trask, 2014; Rask-Madsen & King, 2013). 
Moreover, it has reported that AGEs modulates negatively the 
endothelium-dependent relaxation in experimental diabetes 
(Bucala & Tracey, 1991). Another alteration in metabolism 
caused by glucose excess, which account for endothelial dys-
function is related with protein kinase C (PKC). A ubiquitously 
expressed enzyme that participates in intracellular signaling. 
High concentrations of blood glucose causes de novo synthesis 
of diacylglycerol (DAG) promoting the activation of PKC (De 
Vriese et al., 2000; Rask-Madsen & Kahn, 2012). Deleterious 
effects of this pathway include an increase in expression of ET-1, 
vascular adhesion molecules (I-CAM / V-CAM), pro-inflamma-
tory cytokines, growth factors, NADPH oxidase activity and at 
the same time decrease in eNOS activity (Hwang & Kim, 2014; 
Roberts & Porter, 2013). In the same way, it is believed that 
sorbitol pathway is also responsible for diabetic complications, 
disrupting the antioxidant defense, activating PKC pathway 
which results in oxidative stress (Obrosova, 2005). Another con-
sistent mechanisms involved in endothelial dysfunction in the 
presence of diabetes are the reduction of endothelial progenitor 
cells (EPCs), endoplasmatic reticulum stress, insulin resistance 
in vascular cells, alterations in expression of vascular endothe-
lial growth factor (VEGF) and transforming growth factor beta 
(TGF-β) (Avogaro et al., 2008; Rask-Madsen & King, 2013). 
In an attempt to preserve or to diminish endothelial dys-
function in DM, at least two approaches have been used. A 
primary therapy, lifestyle modifications for subjects without 
cardiovascular risk factors whereas in a secondary therapy, 
the aim is to preserve or improve the function of injured en-
dothelium, avoiding the progression of more damage (Park & 
Park, 2015).
Physical exercise is recognized as valuable therapeutic strat-
egy to improve endothelium-dependent dilation in conduit ar-
teries and in the microcirculation and arterial function (Phillips, 
Mahmoud, Brown, & Haus, 2015). Thus, lifestyle modifications 
is crucial for management of DM in children and adults  and 
it has been recommended  by American Diabetes Association 
(Montero, Walther, Benamo, Perez-Martin, & Vinet, 2013). 
Regarding flow-mediated dilation, evidence has shown that 
FMD is strongly predictive of future cardiovascular events in 
DM. However, others biomarkers should be examined because 
some endothelial dysfuction in diabetic patients is not solely 
related to NO-deficiency. Indeed, recent study found no asso-
ciation between endothelial dysfunction and adults with DM1 
and DM2 measured by FMD. According to the authors, this 
result can be explained by a sophisticated selection of controls 
groups considering confounders factors such as age, body mass 
index, smoking and use of antihypertensive drugs  (Empen et 
al., 2013)the validity of this finding may be limited by the lack 
of adequate adjustment for further cardiovascular confounders. 
We assessed endothelial function as measured by flow-mediated 
dilation (FMD. On the other hand, most of studies have shown 
an increase in forearm blood flow and endothelium dependent 
dilation after exercise intervention in DM1 and DM2 subjects 
(de Moraes, Van Bavel, Gomes, & Tibiriçá, 2016; Fuchsjäger-
Mayrl., et al 2002; Kwon et al., 2011; Maiorana et al., 2001). 
In addition, a meta-analysis including over than 5.000 subjects 
reported that increased FMD was associated with reduction 
in the incidence of cardiovascular events (Inaba, Chen, & 
Bergmann, 2010). Another recent meta-analysis involving a total 
of 217 subjects with T2DM, confirmed that exercise training 
increases nearly  2.23% the FMD index which can represent 
the beneficial effect of exercise for this population, preventing 
cardiovascular complications (Montero et al., 2013). Regarding 
the time-course of vascular adaptations, the improvement on 
endothelial function in middle-aged patients with T2DM in re-
sponse to aerobic exercise training was observed after 2 weeks, 
and the impact of exercise was preserved after 8 weeks. This 
finding seems to be a different response compared with healthy 
subjects and clinically relevant for this population (Schreuder, 
Green, Nyakayiru, Hopman, & Thijssen, 2015).
The beneficial effects of exercise training on endothelial 
function have been attributed to a variety of mechanisms, 
involving local and systemic factors (Green, 2009). Regarding 
diabetic condition, programs of exercise structured with at least 
8 weeks have a positive impact on glycemic control, and this 
effect can be independent of weight loss (Boulé, Haddad, Kenny, 
Wells, 2001). With regards the control of glucose metabolism, 
a study discussed about the importance of exercise to restore or 
improve insulin sensitivity that is considered a determinant of 
the therapeutic action of physical exercise (Phillips et al., 2015). 
One of the most significantly consequences of regular exer-
cise is the increase in NO bioavailability (Zanesco & Antunes, 
2007). Both acute and chronic sessions increase the blood flow, 
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resulting in augmented shear stress on endothelial cells, which 
convert the mechanical stimulus in biochemical signals. The 
immediate effect is the greater release of NO that occurs due 
to enhanced expression/activity of eNOS or up-regulation of 
antioxidant enzymes such as superoxide dismutase, catalase 
and glutathione peroxidase also represents a positive effect of 
an active lifestyle increasing NO bioavailability. Finally, the 
reduced expression of oxidant enzymes, mainly NADPH oxi-
dase, favors the reduction of free radicals generation. Together, 
all these molecular mechanisms, collaborate for diminished NO 
degradation, improving FMD and/or endothelium function that 
reflects a a better prognostic for DM  (Ashor et al., 2015; Gielen, 
Schuler, & Adams, 2010)resistance or combined. 
Regarding progenitor endothelial cells, it has been proposed 
that exercise training stimulates the production of this type of 
cell by bone marrow that is capable to differentiate into mature 
endothelial cell (Steiner et al., 2005).
The recommendation of exercise in particular to T2DM is a 
150 min of moderate-to-vigorous intensity of aerobic exercise 
weekly, in a minimum of 3 days per week. Resistance exer-
cise is an important complement to aerobic exercise since it 
has been demonstrated that this type of exercise promotes a 
long lasting effect on blood glucose uptake as compared with 
aerobic exercise in T1DM patients (Yardley et al., 2013)small 
studies have found that resistance exercise (weight lifting. 
The plan of training should respect individuality, based on 
comorbidities, contraindications and realistic goals (Mendes 
et al., 2015). 
Conclusions
Advances on assessment of endothelial function in last 
decades, mainly through the non-invasive techniques have 
facilitated either basic or clinical researches in cardiovascular 
and endocrine fields. The developing of flow mediated-dilation 
method has been a progress allowing to understand the vascular 
function or dysfunction under different conditions and interven-
tions as well as it is useful to stratify the cardiovascular risk 
and progression of chronic diseases. However, standardization 
of methods is a critical point to achieve a valuable prognostic 
result. In diabetes state, this technique is helping to detect the 
disease progression and the effects of exercise training on endo-
thelial function according to intensity and duration of practice 
prescription in clinical trials. 
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